These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18161389)

  • 1. A conversation with Cary Presant.
    Presant C
    Manag Care Interface; 2007 Sep; 20(9):32-3, 37. PubMed ID: 18161389
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complementary therapy in NSCLC. Supportive treatment in thoracic oncology. Management of chemotherapy induced anaemia and neutropenia, nausea and vomiting and bone metastases].
    Bréchot JM
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S100-16S104. PubMed ID: 17268345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline evaluation of assessment, information, and management patterns in a national quality improvement project.
    Johnson G; Fortner B; Moore K; Tauer KT; Zhu L; Schwartzberg LS;
    J Support Oncol; 2005; 3(6 Suppl 4):36-7. PubMed ID: 16355562
    [No Abstract]   [Full Text] [Related]  

  • 4. Nausea and vomiting, quality of life, and the oncology nurse.
    Grant M
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):5-7. PubMed ID: 9282375
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction.
    Shima Y; Ohtsu A; Shirao K; Sasaki Y
    Jpn J Clin Oncol; 2008 May; 38(5):354-9. PubMed ID: 18490369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites.
    Oh SY; Kwon HC; Lee S; Lee DM; Yoo HS; Kim SH; Jang JS; Kim MC; Jeong JS; Kim HJ
    Jpn J Clin Oncol; 2007 Dec; 37(12):930-5. PubMed ID: 18211984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TITAN: modifying an innovative American program for use with a European audience.
    Ahlberg K; Dielenseger P; Dolan S; Foubert J; Munoz M; Ouwerkerk J; Uhlenhopp M; Wujcik D; ;
    J Support Oncol; 2005; 3(6 Suppl 4):34-5. PubMed ID: 16355561
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncology and specialty drug management in managed care.
    Navarro RP
    Manag Care Interface; 2007 Sep; 20(9):25-6, 29. PubMed ID: 18161387
    [No Abstract]   [Full Text] [Related]  

  • 10. Supportive therapeutic techniques in high-emetogenic cancer chemotherapy.
    Stockhorst U
    Klin Padiatr; 2008; 220(6):330-2. PubMed ID: 18949666
    [No Abstract]   [Full Text] [Related]  

  • 11. Aprepitant--where do we stand in the control of chemotherapy-induced nausea and vomiting?
    Sarcev T; Secen N; Zaric B; Milovancev A
    J BUON; 2008; 13(3):333-9. PubMed ID: 18979546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes.
    Hawkins R; Grunberg S
    Clin J Oncol Nurs; 2009 Feb; 13(1):54-64. PubMed ID: 19193549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of nausea and vomiting after chemotherapy.
    Park VJ; Trovato JA
    Am J Health Syst Pharm; 2004 Apr; 61(7):722-3. PubMed ID: 15119578
    [No Abstract]   [Full Text] [Related]  

  • 14. The misuse/abuse of antihistamine antiemetic medication (cyclizine) by cancer patients.
    Bailey F; Davies A
    Palliat Med; 2008 Oct; 22(7):869-71. PubMed ID: 18718990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
    Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Supportive care in cancer: concepts, achievements and challenges].
    Bauvet F; Klastersky J; Awada A
    Bull Cancer; 2008 Mar; 95(3):381-8. PubMed ID: 18390421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acupressure for chemotherapy-associated nausea and vomiting in children.
    Jones E; Isom S; Kemper KJ; McLean TW
    J Soc Integr Oncol; 2008; 6(4):141-5. PubMed ID: 19134445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability.
    Gore L; Chawla S; Petrilli A; Hemenway M; Schissel D; Chua V; Carides AD; Taylor A; Devandry S; Valentine J; Evans JK; Oxenius B;
    Pediatr Blood Cancer; 2009 Feb; 52(2):242-7. PubMed ID: 18985740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal patch tailors antinausea treatment.
    Morrow T
    Manag Care; 2008 Dec; 17(12):47-8. PubMed ID: 19127767
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I/IIa study of combination chemotherapy with CKD-602 and cisplatin in patients with recurrent epithelial ovarian cancer.
    Kim HS; Kang SB; Seo SS; Han SS; Kim JW; Park NH; Kang SB; Lee HP; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():627-34. PubMed ID: 19723113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.